Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 3/2009

01.03.2009 | Short Communication

11C-Acetate PET imaging for renal cell carcinoma

verfasst von: Nobuyuki Oyama, Hidehiko Okazawa, Naoya Kusukawa, Taisei Kaneda, Yoshiji Miwa, Hironobu Akino, Yasuhisa Fujibayashi, Yoshiharu Yonekura, Michael J. Welch, Osamu Yokoyama

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In this study, we investigated the effectiveness of positron emission tomography (PET) with 11C-acetate (AC) for evaluation of renal cell carcinoma.

Methods

Enrolled in the study were 20 patients with suspected renal tumour, one of whom had three renal lesions. In all, 22 renal lesions were evaluated. Following administration of 350 MBq (10 mCi) of AC, whole-body PET images were obtained. Based on these PET findings, kidney lesions were scored as positive or negative. The PET results were correlated with the CT findings and histological diagnosis after surgery.

Results

In 18 patients, 20 tumours were diagnosed as renal cell carcinoma. Lesions in the remaining two patients were diagnosed as complicated cyst without malignant tissue. Of the 20 renal cell carcinomas. 14 (70%) showed positive AC PET findings; 6 were negative. The two patients with complicated cyst had negative AC PET findings. Of the 20 renal cell carcinomas, 19 were clear-cell carcinoma and 1 was a papillary cell carcinoma. This papillary cell carcinoma showed high AC uptake.

Conclusion

AC demonstrates marked uptake in renal cell carcinoma. These preliminary data show that AC is a possible PET tracer for detection of renal cancer.
Literatur
1.
Zurück zum Zitat Bosniak MA. The current radiological approach to renal cysts. Radiology 1986;158:1–10.PubMed Bosniak MA. The current radiological approach to renal cysts. Radiology 1986;158:1–10.PubMed
2.
Zurück zum Zitat Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991;179:307–317.PubMed Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991;179:307–317.PubMed
3.
Zurück zum Zitat Hartman DS, Aronson S, Frazer H. Current status of imaging indeterminate renal masses. Radiol Clin North Am 1991;29:475–496.PubMed Hartman DS, Aronson S, Frazer H. Current status of imaging indeterminate renal masses. Radiol Clin North Am 1991;29:475–496.PubMed
4.
Zurück zum Zitat Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996;198:785–788.PubMed Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996;198:785–788.PubMed
5.
Zurück zum Zitat Shreve PD, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med 1995;198:1595–1601. Shreve PD, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med 1995;198:1595–1601.
6.
Zurück zum Zitat Oyama N, Akino H, Kanamaru H, Suzuki Y, Muramoto S, Yonekura Y. 11C-acetate PET imaging of prostate cancer. J Nucl Med 2002;43:181–186.PubMed Oyama N, Akino H, Kanamaru H, Suzuki Y, Muramoto S, Yonekura Y. 11C-acetate PET imaging of prostate cancer. J Nucl Med 2002;43:181–186.PubMed
7.
Zurück zum Zitat Oyama N, Miller TR, Dehdashti F, Siegel BA, Fischer KC, Michalski JM, et al. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 2003;44:549–555.PubMed Oyama N, Miller TR, Dehdashti F, Siegel BA, Fischer KC, Michalski JM, et al. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 2003;44:549–555.PubMed
8.
Zurück zum Zitat Kotzerke J, Linne C, Meinhardt M, Steinbach J, Wirth M, Baretton G, et al. [1-11C]Acetate uptake is not increased in renal cell carcinoma. Eur J Nucl Med Mol Imaging 2007;34:884–888.PubMedCrossRef Kotzerke J, Linne C, Meinhardt M, Steinbach J, Wirth M, Baretton G, et al. [1-11C]Acetate uptake is not increased in renal cell carcinoma. Eur J Nucl Med Mol Imaging 2007;34:884–888.PubMedCrossRef
Metadaten
Titel
11C-Acetate PET imaging for renal cell carcinoma
verfasst von
Nobuyuki Oyama
Hidehiko Okazawa
Naoya Kusukawa
Taisei Kaneda
Yoshiji Miwa
Hironobu Akino
Yasuhisa Fujibayashi
Yoshiharu Yonekura
Michael J. Welch
Osamu Yokoyama
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2009
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-008-0981-0

Weitere Artikel der Ausgabe 3/2009

European Journal of Nuclear Medicine and Molecular Imaging 3/2009 Zur Ausgabe